COCRYSTAL PHARMA INC (COCP) Forecast, Price Target & Analyst Ratings

NASDAQ:COCP • US19188J4094

Current stock price

1.46 USD
+0.07 (+5.04%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for COCRYSTAL PHARMA INC (COCP).

Forecast Snapshot

Consensus Price Target

Price Target
$8.16
+ 458.90% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 18, 2026
Period
Q1 / 2026
EPS Estimate
-$0.15
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$8.16
Upside
+ 458.90%
From current price of $1.46 to mean target of $8.16, Based on 8 analyst forecasts
Low
$6.06
Median
$8.16
High
$10.50

Price Target Revisions

1 Month
33.33%
3 Months
0.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for COCP. The average price target is 8.16 USD. This implies a price increase of 458.9% is expected in the next year compared to the current price of 1.46.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

COCP Current Analyst RatingCOCP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

COCP Historical Analyst RatingsCOCP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
COCP was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about COCP.
In the previous month the buy percentage consensus was at a similar level.
COCP was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-06-20HC Wainwright & Co.Maintains Buy -> Buy
2025-01-22HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-22HC Wainwright & Co.Maintains Buy -> Buy
2024-05-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-04-04HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-20HC Wainwright & Co.Reiterate Buy -> Buy
2024-01-03HC Wainwright & Co.Maintains Buy -> Buy
2023-12-04HC Wainwright & Co.Reiterate Buy -> Buy
2023-10-04HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-15HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-11HC Wainwright & Co.Reiterate Buy -> Buy
2023-06-02HC Wainwright & Co.Reiterate Buy -> Buy
2023-05-24HC Wainwright & Co.Maintains Buy -> Buy
2023-01-24HC Wainwright & Co.Maintains Buy
2022-11-07HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 18, 2026
Period
Q1 / 2026
EPS Estimate
-$0.15
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
33.48%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-7.14%
EPS (3 Months)
-7.14%

Next Earnings Summary

COCP is expected to report earnings on 5/18/2026. The consensus EPS estimate for the next earnings is -0.15 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
COCP revenue by date.COCP revenue by date.
6.56M2.01M
-69.36%
-100.00%
EBITDA
YoY % growth
COCP ebitda by date.COCP ebitda by date.
-8.97M
-9.93%		-2.21M
75.36%		-9.43M
-326.70%		N/A
-48.78%		N/A
-27.94%		-20.137M
-16.82%		-21.044M
14.76%		-17.479M
2.21%		N/AN/AN/A
EBIT
YoY % growth
COCP ebit by date.COCP ebit by date.
-9.02M
-9.20%		-2.31M
74.39%		-9.59M
-315.15%		-14.707M
-48.28%		-40.93M
-27.57%		-19.821M
-16.64%		-20.628M
14.93%		-9.078M
49.57%		-15.3M
-68.54%		-18.36M
-20.00%		N/A
Operating Margin
COCP operating margin by date.COCP operating margin by date.
N/A-35.21%-477.11%N/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
COCP eps by date.COCP eps by date.
N/A-0.72
76.47%		-2.28
-216.67%		-1.96
15.79%		-4.18
-146.35%		-2.14
59.83%		-1.97
8.95%		-0.81
54.34%		-0.81
-2.00%		-0.99
-22.78%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.15
33.48%		-0.17
15.85%		-0.18
6.05%		-0.18
-8.00%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-2.244M
4.14%		-2.55M
-20.97%		-2.754M
-31.83%		-2.958M
-19.23%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

COCP Yearly Revenue VS EstimatesCOCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2019 2020 2M 4M 6M
COCP Yearly EPS VS EstimatesCOCP Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -1 -2 -3 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

COCRYSTAL PHARMA INC / COCP Forecast FAQ

What do analysts expect the price target to be for COCRYSTAL PHARMA INC (COCP)?

8 analysts have analysed COCP and the average price target is 8.16 USD. This implies a price increase of 458.9% is expected in the next year compared to the current price of 1.46.

Can you provide the upcoming earnings date for COCRYSTAL PHARMA INC?

COCRYSTAL PHARMA INC (COCP) will report earnings on 2026-05-18.

Can you provide the consensus estimates for COCRYSTAL PHARMA INC next earnings?

The consensus EPS estimate for the next earnings of COCRYSTAL PHARMA INC (COCP) is -0.15 USD and the consensus revenue estimate is 0 USD.

What is the consensus rating for COCRYSTAL PHARMA INC (COCP) stock?

The consensus rating for COCRYSTAL PHARMA INC (COCP) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.